Your browser doesn't support javascript.
loading
Methamphetamine induces neuronal death: Evidence from rodent studies.
Sabrini, Sabrini; Russell, Bruce; Wang, Grace; Lin, Joanne; Kirk, Ian; Curley, Louise.
Afiliación
  • Sabrini S; School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland 1142 New Zealand. Electronic address: snol421@aucklanduni.ac.nz.
  • Russell B; School of Pharmacy, University of Otago, New Zealand. Electronic address: bruce.russell@otago.ac.nz.
  • Wang G; Department of Psychology, Faculty of Health and Environmental Sciences, Auckland University of Technology, New Zealand. Electronic address: grace.wang@aut.ac.nz.
  • Lin J; School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand. Electronic address: joanne.lin@auckland.ac.nz.
  • Kirk I; School of Psychology, Faculty of Science, The University of Auckland, New Zealand. Electronic address: i.kirk@auckland.ac.nz.
  • Curley L; School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland 1142 New Zealand. Electronic address: l.curley@auckland.ac.nz.
Neurotoxicology ; 77: 20-28, 2020 03.
Article en En | MEDLINE | ID: mdl-31812708
ABSTRACT
Animal studies have consistently observed neuronal death following methamphetamine (MA) administration, however, these have not been systematically reviewed. This systematic review aims to present the evidence for MA-induced neuronal death in animals (rodents) and identify the regions affected. Locating the brain regions in which neuronal death occurs in animal studies will provide valuable insight into the linkage between MA consumption and the structural alterations observed in the human brain. The data were collected from three databases Scopus, Ovid, and the Web of Science. Thirty-seven studies met the inclusion criteria and were divided into two sub-groups, i.e. acute and repeated administration. Twenty-six (of 27) acute and ten (of 11) repeated administration studies observed neuronal death. A meta-analysis was not possible due to different variables between studies, i.e. species, treatment regimens, withdrawal periods, methods of quantification, and regions studied. Acute MA treatment induced neuronal death in the frontal cortex, striatum, and substantia nigra, but not in the hippocampus, whereas repeated MA administration led to neuronal loss in the hippocampus, frontal cortex, and striatum. In addition, when animals self-administered the drug, neuronal death was observed at much lower doses than the doses administered by experimenters. There is some overlap in the regions where neuronal death occurred in animals and the identified regions from human studies. For instance, gray matter deficits have been observed in the prefrontal cortex and hippocampus of MA users. The findings presented in this review implicate that not only does MA induce neuronal death in animals, but it also damages the same regions affected in human users. Despite the inter-species differences, animal studies have contributed significantly to addiction research, and are still of great assistance for future research with a more relevant model of compulsive drug use in humans.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encéfalo / Muerte Celular / Estimulantes del Sistema Nervioso Central / Metanfetamina / Neuronas Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Animals Idioma: En Revista: Neurotoxicology Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encéfalo / Muerte Celular / Estimulantes del Sistema Nervioso Central / Metanfetamina / Neuronas Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Animals Idioma: En Revista: Neurotoxicology Año: 2020 Tipo del documento: Article